The DEA has proposed new rules that could significantly impact telemedicine prescription of non-narcotic medications (Schedule III, IV, and V). These rules require in-person evaluations by prescribing physicians, additional record-keeping, two-way audio communication, and limited medication supplies. This would affect patients on long-term therapies like hormone replacement, creating unnecessary burdens for both doctors and patients.
These rules could harm doctors by increasing administrative tasks, limiting prescription options, and reducing scheduling flexibility. Patients may face difficulties such as mandatory in-person visits, frequent refills, and higher costs. However, the rules have not yet taken effect, and there is still time to petition the DEA to reconsider through public comments.
The rules have not yet taken effect, and there’s still time to petition the DEA to reconsider. Public comments can influence the outcome, so sharing your thoughts on the matter is crucial. The due date for comments on March 31, 2023, only a few days away. Read below to act and defend your access to telemedicine.
These rules could harm doctors by increasing administrative tasks, limiting prescription options, and reducing scheduling flexibility. Patients may face difficulties such as mandatory in-person visits, frequent refills, and higher costs. However, the rules have not yet taken effect, and there is still time to petition the DEA to reconsider through public comments.
The rules have not yet taken effect, and there’s still time to petition the DEA to reconsider. Public comments can influence the outcome, so sharing your thoughts on the matter is crucial. The due date for comments on March 31, 2023, only a few days away. Read below to act and defend your access to telemedicine.
ED Drugs Have Benefits Beyond Treating Erectile Dysfunction
ED Drugs like Viagra, Levitra, Cialis and Stendra Have Benefits Beyond Treating Erectile Dysfunction. It was associated with a re-invigorated
www.excelmale.com
Last edited: